glp-1 drugs in development Timeline of discovery and clinical development. (a) Key events Science's 2023 Breakthrough: GLP-1R Agonists

In laboratory research, Lipo-C is commonly studied for: Lipid metabolism and fat oxidation pathways Methylation cycle and homocysteine regulation studies Vitamin B6-dependent enzymatic reactions Vitamin B12 involvement in cellular energy production Hepatic lipid processing and transport mechanisms Amino acid metabolism and biochemical conversion systems Because of its combination of metabolic cofactors, Lipo-C is widely used in nutritional biochemistry and metabolic pathway research

A recent review has documented this synergy (McGuire et al., Curr Rev Musculoskelet Med 2025)

The human studies only contained a small number of subjects and often lacked data on factors with a potential impact on neonatal outcomes such as BMI, age, smoking, drug treatment characteristics (dose and administration time) and trimester of exposure

Drug Interactions Some drugs (e.g., diuretics, corticosteroids, antihypertensives, carbonic anhydrase inhibitors) can affect metformin's safety and effectiveness